Permira Nears Deal to Acquire U.K. Drugmaker Quotient

(Bloomberg) -- Permira is nearing a deal for drugmaker Quotient Sciences that values the U.K. firm at about 600 million pounds ($745 million) including debt, people familiar with the matter said.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.